QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Proprietary Covid-ID Lab to Launch in Germany
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, announced that Marx Pharma GmbH, the company’s distribution, storage and logistics partner, is launching Covid-ID Lab, XPhyto’s 25-minute SARS-CoV-2 (COVID-19) RT-PCR test system in Germany; the product will launch on May 25. The announcement noted that the proprietary Covid-ID Lab will be priced within the range of commonly available COVID-19 PCR test products already on the market and that initial manufacturing capacity has been determined; additional manufacturing capacity is also available if needed. XPhyto’s Covid-ID Lab requires only a 20-minute PCR run…